Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Investor AB is a Swedish publicly traded investment and holding company founded by the Wallenberg family in 1916. The company owns significant stakes in listed Nordic and international companies and also controls a portfolio of wholly owned subsidiaries through Patricia Industries. Although Investor AB has meaningful healthcare exposure through portfolio companies such as Mölnlycke, Laborie, and Advanced Instruments, it is not itself a biotechnology, pharmaceutical, or healthcare operating company. Its business centers on long-term active ownership, capital allocation, board participation, and value creation across industrial, financial, technology, and selected healthcare assets. For a biotech analyst, Investor AB is best understood as a strategic owner and allocator of capital rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Investor AB.